Drugs / CTX
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02294344 Comparator | Jun 2014 → Apr 2017 | anti-neutrophil cytoplasmic antibody-associated vasculitis | Zhi-Hong Liu, M.D. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02294344 ↗ |
| Route | Intravenous | “intravenous cyclophosphamide (IV-CTX) pulse therapy” NCT02294344 ↗ |